期刊文献+

乌梅丸熏洗联合肛周皮下游离术对肛门瘙痒症患者PAR-2靶点的研究

INTERVENTION EFFECT OF FUMIGATION AND WASHING WITH WUMEI PILL COMBINED WITH FREE PERIANAL SUBCUTANEOUS OPERATION ON EXPRESSIONS OF PROTEASE-ACTIVATED RECEPTOR-2 IN PERIANAL PRURITUS PATIENTS
下载PDF
导出
摘要 目的通过研究治疗组(乌梅丸熏洗联合肛周皮下游离术)针对肛门瘙痒症皮损PAR-2(蛋白酶活化受体-2)的表达量,从而客观评价本方案的治疗效果。方法选择2013年1月至2014年10月肛门瘙痒症术后患者,随机分为治疗组20例、对照组20例、空白组10例。取术后三组第1、3、7 d的肛周皮损皮肤,采用实时荧光定量RT-PCR检测PAR-2编码基因的表达量,并进行统计分析。结果治疗组术后第1、3、7 d较对照组及空白组的表达量明显下降,且有显著性差异(P<0.05)。结论乌梅丸联合肛周皮下游离术对肛门瘙痒症有良好的治疗效果。 Objective:To investigate intervention effect of fumigation and washing with Wumei pill combined with free perianal subcutaneous operation on the expression of protease-activated receptor-2(PAR-2). And the efficacy of this treatment was evaluated objectively. Methods:50 postoperative patients with perianal pruritus were selected from January 2013 to October 2014 and divided randomly into 3 groups as the experimental group(n = 20),the control group(n = 20) and the blank group(n = 10). The expression of PAR-2 was detected with RT-PCR in all patients' lesion skin collected on day 1,3 and 7 after operation. All acquired data were analyzed by statistical software. Results:The expression of PAR-2 in experimental group was much lower than that in the control group and the blank group on day 1,3 and 7 after operation with significant difference(P 0.05). Conclusion:Wumei pill combined with free perianal subcutaneous operation had a good efficacy in treating perianal pruritus.
作者 黄文武
出处 《井冈山大学学报(自然科学版)》 2015年第5期100-102,共3页 Journal of Jinggangshan University (Natural Science)
基金 江西省卫生和计生委课题计划项目(2013A187)
关键词 PAR-2 肛门瘙痒症 乌梅丸熏洗 肛周皮下游离术 PAR-2 perianal pruritus fumigation and washing with Wumei pill free perianal subcutaneous operation
  • 相关文献

参考文献8

二级参考文献78

  • 1赵毅.中药外洗内服治疗肛门瘙痒症26例[J].中医外治杂志,2006,15(2):11-11. 被引量:4
  • 2潘芳杰,黄凤.中药加封闭治疗肛门瘙痒症60例[J].新疆中医药,2007,25(1):29-29. 被引量:1
  • 3Steinhoff M,Neisius U,Ikoma A,et al.Proteinase-activated receptor-2 mediates itch:a novel pathway for pruritus in human skin.J Neurosci,2003,23(15):6176-6180.
  • 4Nakano T.Andoh T.Tayama M.et al.Effects of topical application of tacrolimus on acute itch-associafted responses in mice.Biol Pharm Bull,2008,31 (4):752-754.
  • 5Williams HC,Burney PG,Hay RJ,et al.The U.K.Working Party's Diagnostic Criteria for Atopic Dermatitis:I.Derivation of a minimum set of discriminators for atopic dermatitis.Br J Dermatol,1994,131(3):383-396.
  • 6Rajka G,Langcland T.Grading of the severity of atopic dermatitis.Aeta Derm Vencrcol Suppl (Stockh),1989,144:13-14.
  • 7D'Andrea MR,Derian CK,Leturcq D,et al.Characterization of protease-activated receptor-2 immnoreactivity in normal human tissues.J Histochem Cytochem,1998,46(2):157-164.
  • 8Steinhoff M,Corvera CU,Thoma MS,et al.Protcinase-activated receptor-2 in human skin:tissue distribution and aetivation of keratinocytes hy mast cell tryptase.Exp Dermatol,1999,8(4):282-294.
  • 9Zhu Y,Wang XR,Peng C,et al.Induction of leukotriene B(4)and prostaglandin E (2) release from kcratinocytes by proteascactivated receptor-2-aetivating peptide in ICR mice. Int Immunopharmacol,2009,9(11):1332-1336.
  • 10Hou L,Kapas S,Cruchley AT,et al.Immunolocalization of protease-activated receptor-2 in skin:receptor activation stimulates interleukin-8 secretion by keratinoeytes in vitro.Immunology.1998,94(3):356-362.

共引文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部